Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Other disposition President and CEO disposed of 20,000 shares (other)
  2. 4 Exercise or conversion Chief Financial Officer acquired 5,834 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  4. 4 Shares withheld for taxes President and CEO gave up 2,055 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 10,075 shares (to pay taxes)
  14. 4 Exercise or conversion Director acquired 87,801 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  16. 4 Shares withheld for taxes President and CEO gave up 16,115 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Director bought 2,567 shares at $7.79 ($19,997)
  20. 4 Open-market buy Director bought 5,000 shares at $7.95 ($39,750)

Page 3 of 23 · 459 filings